SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-153621
Filing Date
2014-04-23
Accepted
2014-04-23 07:31:53
Documents
3
Period of Report
2014-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d714290d8k.htm 8-K 21256
2 EX-5.1 d714290dex51.htm EX-5.1 5568
3 EX-10.1 d714290dex101.htm EX-10.1 174810
  Complete submission text file 0001193125-14-153621.txt   202776
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 14777440
SIC: 2834 Pharmaceutical Preparations